By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – The US Food and Drug Administration has cleared for marketing Abbott's Vysis CLL FISH Probe Kit for determining the prognosis of patients with chronic lymphocytic leukemia.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PLOS this week: oral microbiomes of dogs and their owners, Plasmodium vivax population structure, and more.
The American Society of Human Genetics has issued a position statement on genetic testing of children.
The White House seeks to update how biotechnology products are regulated.
Team science leads some researchers to get lost in the shuffle, the Chronicle of Higher Education reports.